Mechanism of poly-SUMO chain recognition by the ubiquitin ligase RNF4

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Conjugation and deconjugation with the Small Ubiquitin-like Modifier (SUMO) protein is an important regulatory process in controlling gene expression. Poly-SUMO chains have been implicated in cellular processes such as meiosis, genome maintenance and stress response; and more than 300 poly-SUMO conjugates have been identified in cultured eukaryotic cells. Lys11-linked poly-SUMO chains are recognized by a wide range of effector proteins that contain SUMO interaction motifs (SIMs). As has been observed for poly-ubiquitin chains it is predicted that specific recognition of SUMO chains is based on conformational preferences. Apart from studies on individual SUMO domains interacting with a single SIM, there is no information regarding the conformational properties of poly-SUMO bound to SIM-containing proteins in solution. Deciphering the details of how Lys11-linked poly-SUMO chains are recognized by effector molecules such as RNF4 is vital for a better understanding of this important regulatory mechanism.

This proposal aims to characterize the solution structure, dynamics, and interactions of poly-SUMO chains. We will use NMR and SAXS approaches to determine the three-dimensional conformation of Lys11-linked tetra-SUMO chain, free in solution, and in complex with the SUMO-interaction-motif (SIM) protein, RNF4, which contains 4 canonical SIM motifs. Using a combination of long-range, orientational constraints derived from residual dipolar coupling measurements, complemented with distance information from paramagnetic relaxation enhancements and pseudocontact shifts introduced by paramagnetic labels, we will derive models for interdomain or intermolecular interfaces. The overall structure and dynamics of the polySUMO-RNF4 complex will be probed by site-directed mutagenesis and functional readouts.

This basic "blue-sky" research project will have an impact on a fundamental process in cellular regulation. The following beneficiaries have been identified. Methods of how they will benefit and what will be done to ensure that they have the opportunity to benefit from this research are detailed. The applicants SM and RH will take collective responsibility for maximizing impact.
1. Beneficiary one: SM and RH research groups The proposal will support an established collaboration between the SM and RH groups working on the interaction between poly-SUMO chains and multiple SIMs. We have maintained active communication channels between the groups by organising regular joint meetings, conferences calls and actively promoting the exchange of research staff. In addition to ensuring that both group thrive during this collaboration, our proactive approach to communication will likely fuel future ventures in related areas. The added value of this collaboration is that it will integrate the NMR expertise of the SM group with the molecular biology and biochemistry skills of the RH group. This will benefit the RH group by making them more aware of modern methods of structural analysis that can be applied to ubiquitin and ubiquitin-like proteins.It will also benefit the SH group by giving them access to quantitative biochemical and functional assays for the activity of proteins involved in pathways of ubiquitin and ubiquitin-like protein modification.
2. Beneficiary two: PDRAs and students. The PDRAs and any undergraduate, postgraduate or intern students contribute to the knowledge economy and increase the economic competitiveness of the UK. SM and RH will train PDRAs, and students in key techniques and good laboratory practice and encourage an innovative approach to research. Those involved will be encouraged to present their work as widely as possible and to communicate with both short-term and long-term user groups. Training in communication will be provided if necessary. Both Universities have a highly active staff development programme, which includes courses on presenting science to a lay audience, writing research papers and proposal, career workshops. It is worth noting that this project has already contributed to the training and progression for several undergraduate students, exchange students and Master Students including our BBSRC MRes in Structural Molecular Biology.
3. Beneficiary three: wider academic community As outlined in our statement on data sharing, we will ensure that research is disseminated widely by the Open Access publication in high-impact journals, presentation at international research meetings, and the development of new collaborations where appropriate and deposition of data into freely-accessible databases (e.g. PDB).
4. Beneficiary four: large Pharma and small Biotech companies Although this is a basic research project, its outcomes will benefit the private sector as SUMO is required for repair of damaged DNA in human cells and that SUMO is recruited to sites of DNA damage induced by ionising radiation. By revealing a deeper molecular understanding of SUMO recognition in the regulation of mammalian cells, this work wil benefit large Pharma (e.g. Pfizer, Novartis, GSK), smaller Biotech companies (Ubiquigent) or not-for-profit organisations that are developing new disease therapies. We will ensure that intellectual property opportunities are maintained by liaison with BBSRC together with Dundee's and Imperial College's technology transfer expertise (IC INNOVATIONS Ltd). This local expertise will advise on how to protect inventions and develop an appropriate IP protection strategy. Furthermore, they will foster relationships with industry partners, to determine the right commercialisation strategy. Where appropriate they will co-invest in new ventures to accelerate development and increase value.